Drugmaker Regulus Therapeutics LLC said Thursday it is expanding a partnership with GlaxoSmithKline, and will begin researching new treatments for hepatitis C. Regulus said it will identify a potential drug candidate in late 2010, and file an application with the Food and Drug Administration in 2011. Regulus ...

GlaxoSmithKline said Wednesday a Senate report criticizing its handling of heart risks with its diabetes drug Avandia "mischaracterizes and distorts" the company's record. In a memo posted online, the British drugmaker takes aim at the highly critical Senate Finance Committee report that has reignited ...

London's FTSE 100 rose at the open on Tuesday, gaining 0.49 percent to 5,378.43 points. The index of leading shares had on Monday shed 0.11 percent to close at 5,352.07. Monday's gains in the mining sector had been offset by losses sustained by pharmaceutical giant GlaxoSmithKline (GSK) after concern over its diabetes ...